Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-18-000907
Filing Date
2018-02-12
Accepted
2018-02-12 16:58:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 p18-0327sc13ga.htm SC 13G/A 60741
  Complete submission text file 0000902664-18-000907.txt   62431
Mailing Address 540 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022 514-281-8082
Senvest Management, LLC (Filed by) CIK: 0001328785 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88541 | Film No.: 18597319
SIC: 3841 Surgical & Medical Instruments & Apparatus